News
-
Congrats to Romain and co-authors for their publication !
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer The protein tyrosine phosphatase SHP2 activates oncogenic pathways downstream of most receptor tyrosine kinases (RTK) and has been implicated in various cancer types. Although allosteric inhibitors of SHP2 have been developed and are currently being evaluated in clinical trials, neither the mechanisms of…
-
N-acetylcysteine overcomes NF1-loss-driven resistance to PI3K alpha inhibition in breast cancer
Congratulations to Priska and co-authors for their publication in Cell Reports Medicine! A lot of work for a great achievement!
-
Welcome to our new PhDs Ioanna and Livio
Ioanna obtained her MSc in Biomedical Sciences from the University of Patras where she also received her BSc in Biology. Her research was focused on unraveling molecular links between the lipoprotein system and metabolic diseases. After completing her studies, she worked at the University of Bern where she examined the therapeutic potential of the modulation…
-
Congratulations Dr Richina!
Congrats to our new Doctor ! Veronica’s defense happened last January, we wish you all the best for the next steps in your career !
-
Congratulations to the BBC 2022 Awards winners !
Congratulations to the lab members who received the following prizes during the Basel Breast Consortium Annual Meeting 2022:
-
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer
Congratulations to Milica and co-authors for their publication in Oncogene !!! Report on Telebasel from 02.10.2022 about it
-
Congrats to Dr. Baptiste and Dr. Priska!
Congrats to our new Doctors ! Baptiste’s defense was in June and Priska’s just a few days ago, we wish you the best for the next steps in your careers !
-
Ana’s paper in the top 10 cancer publications of the EACR!
Congrats to all the authors that contributed to this story ! Please, check it out below
-
Welcome to our new post-doc Maria Rafaeva!
Cell biologist by training, Maria recently completed PhD at BRIC, University of Copenhagen, Denmark. Her work was centered around applications of the extracellular matrix, derived from decellularized tissues, in studying breast and pancreatic cancers progression. Advancing as a cancer researcher, she sets for the next challenge in tackling clinically relevant questions in Momo’s lab, where…
-
Congrats to Marion and Priska, both awarded prizes during the BBC annual meeting 2021
Congratulations to our lab members Marion and Priska who received the following prizes during the Basel Breast Consortium Annual Meeting 2021 in November. BBC Felix Harder Award to Marion Salvador BBC Nancy Hynes Award to Priska Auf der Maur